Bio-Cat, Inc.

Genencor International, Inc.

Land O'lakes, Inc.

Moore, Kenneth Gregory

Christopher S Penet

Christopher Schuler

Sebhat Gebrechristos

Jessica Spears

Edward Schuler

Kelly Gregory

Deborah S Winetzky

Robert Daniel Little, Jr

Caroline Helen Best

Bill L Miller

Gregory S Moore

Edit L Braunstein

Madhu L Kakade

Mary R Higgins

Robert L Dostie

Keith H Germano

Steve C Lamb

K Gregory Moore

Paul B Richards

Tim Emerson

Jane Kitchar

Kenneth Gregory Moore

Robert Daniel Little

A spore-formingspecies, and more particularly, astrain identified as MB40 is provided. Compositions comprising the MB40 strain, methods of making products comprising the same, and methods of using the same are also provided.

Bacillus compositions and uses thereof

The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.

Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase

Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase

A method of treating a proteinaceous material having a first concentration of &#x3b2;-conglycinin, the method including combining the proteinaceous material with an enzyme to form a reaction mixture, the reaction mixture initially having a pH of at least about 7.0 standard pH units, allowing the enzyme to hydrolyze &#x3b2;-conglycinin present in the reaction mixture to form a proteinaceous intermediate, and inactivating the enzyme present in the reaction mixture after a reaction period to form a proteinaceous product, the proteinaceous product having a second concentration of &#x3b2;-conglycinin, the second concentration of &#x3b2;-conglycinin being at least 99 percent less than the first concentration of &#x3b2;-conglycinin.

Protein material

Crystalline cellulose production

Growing community of inventors

Manakin Sabot, VA, United States of America

Christopher S Penet